Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.

Boyrie S, Delmas C, Lemarié A, Lubrano V, Dahan P, Malric L, Luis J, Gilhodes J, Tosolini M, Mouly L, Lehmann M, Toulas C, Cohen-Jonathan Moyal E, Monferran S.

Oncotarget. 2018 Sep 18;9(73):33788-33803. doi: 10.18632/oncotarget.26082. eCollection 2018 Sep 18.

2.

Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.

Malric L, Monferran S, Delmas C, Arnauduc F, Dahan P, Boyrie S, Deshors P, Lubrano V, Da Mota DF, Gilhodes J, Filleron T, Siegfried A, Evrard S, Kowalski-Chauvel A, Moyal EC, Toulas C, Lemarié A.

Mol Cancer Res. 2019 Feb;17(2):384-397. doi: 10.1158/1541-7786.MCR-18-0386. Epub 2018 Sep 28.

PMID:
30266751
3.

[Dermatologic toxicities of immune checkpoint inhibitors].

Sibaud V, Boulinguez S, Pagès C, Riffaud L, Lamant L, Chira C, Boyrie S, Vigarios E, Tournier E, Meyer N.

Ann Dermatol Venereol. 2018 May;145(5):313-330. doi: 10.1016/j.annder.2018.01.047. Epub 2018 Apr 18. Review. French.

PMID:
29678394
4.

Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Malric L, Monferran S, Gilhodes J, Boyrie S, Dahan P, Skuli N, Sesen J, Filleron T, Kowalski-Chauvel A, Cohen-Jonathan Moyal E, Toulas C, Lemarié A.

Oncotarget. 2017 Aug 21;8(49):86947-86968. doi: 10.18632/oncotarget.20372. eCollection 2017 Oct 17. Review.

5.

Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.

Vlashi E, Chen AM, Boyrie S, Yu G, Nguyen A, Brower PA, Hess CB, Pajonk F.

Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1198-206. doi: 10.1016/j.ijrobp.2016.01.005. Epub 2016 Jan 14.

6.

Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment.

Khalifa J, Vieillevigne L, Boyrie S, Ouali M, Filleron T, Rives M, Laprie A.

Radiat Oncol. 2014 Nov 26;9:247. doi: 10.1186/s13014-014-0247-x.

7.

Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer.

Boyrie S, Charra-Brunaud C, Harter V, Ducassou A, Kirova Y, Barillot I, Krzisch C, Lang P, Baron MH, Montbarbon X, Delannes M, Peiffert D.

Brachytherapy. 2014 Jul-Aug;13(4):326-31. doi: 10.1016/j.brachy.2014.03.003.

PMID:
24946972
8.

Cystadenocarcinoma of the parotid: case report of a BRAF inhibitor treatment.

Boyrie S, Fauquet I, Rives M, Genebes C, Delord JP.

Springerplus. 2013 Dec 18;2:679. doi: 10.1186/2193-1801-2-679. eCollection 2013.

Supplemental Content

Loading ...
Support Center